Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples